Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» graft vs host disease
graft vs host disease
Mesoblast scores FDA committee's backing for cell therapy despite some early worries
Fierce Pharma
Fri, 08/14/20 - 12:45 pm
Mesoblast
cell therapy
FDA
Ryoncil
graft vs host disease
Novartis announces phase III study of Jakavi in chronic graft-versus-host disease met primary and key secondary endpoints
Pharmaceutical Business Review
Tue, 07/28/20 - 10:30 am
Novartis
graft vs host disease
Jakavi
Ruxolitinib passes another PhIII test for graft-versus-host disease, a win for Incyte and Novartis
Endpoints
Thu, 07/23/20 - 11:06 am
ruxolitinib
Novartis
Incyte
graft vs host disease
Kadmon’s graft-versus-host disease med on track for 2020 filing
Fierce Biotech
Thu, 05/21/20 - 11:21 pm
Kadmon
belumodsil
graft vs host disease
clinical trials
Novartis, Incyte's Jakafi boosts its case in graft-versus-host disease with another phase 3 win
Fierce Pharma
Wed, 04/22/20 - 10:45 pm
Novartis
Incyte
Jakafi
clinical trials
COVID-19
cytokine storm
graft vs host disease
Equillium Continues Graft-Versus-Host Disease Trial, Pauses 2 Others
Xconomy
Fri, 03/27/20 - 08:22 pm
Equillium
clinical trials
COVID-19
graft vs host disease
MaaT bags €18M to test microbiome modulators in cancer patients
Fierce Biotech
Wed, 02/5/20 - 10:15 am
MaaT Pharma
solid tumors
graft vs host disease
Incyte stock slammed after study fails to hit goal
Marketwatch
Thu, 01/2/20 - 11:44 pm
Incyte
clinical trials
itacitinib
graft vs host disease
Bristol-Myers Squibb gets FDA breakthrough therapy status for Orencia to prevent GvHD
Pharmaceutical Business Review
Thu, 12/5/19 - 10:06 am
Bristol-Myers Squibb
Orencia
graft vs host disease
FDA
breakthrough status
Upcoming events – key tests approach for Kadmon and Surface
EP Vantage
Fri, 11/1/19 - 06:53 pm
Kadmon
graft vs host disease
Surface Oncology
SRF373/NZV930
Incyte's cash cow Jakafi chugs along with positive frontline results for GVHD
Endpoints
Wed, 10/16/19 - 12:23 pm
Incyte
FDA
graft vs host disease
Jakafi
Incyte (INCY) Receives FDA Nod for Label Expansion of Jakafi
Yahoo/Zacks.com
Tue, 05/28/19 - 10:07 am
FDA
Incyte
Jakafi
graft vs host disease
Mesoblast poised to file cell therapy for GVHD in US
Pharmaforum
Wed, 04/17/19 - 09:44 am
Mesoblast
stem cells
graft vs host disease
FDA
remestemcel-L
MaaT Pharma Announces Second Positive DSMB Safety Assessment of Ph II Study in Acute GvHD
CP Wire
Wed, 04/10/19 - 11:31 pm
MaaT Pharma
graft vs host disease
MaaT013
MaaT Pharma Announces Second Positive DSMB Safety Assessment of Ph II Study in Acute GvHD
Wed, 04/10/19 - 09:24 pm
MaaT Pharma
graft vs host disease
MaaT013
Incyte Down as FDA Extends Review Period of Jakafi for GVHD
Yahoo/Zacks.com
Sat, 02/9/19 - 12:23 pm
Incyte
FDA
Jakafi
graft vs host disease
Equillium's EQ001 Granted FDA Fast Track Designation for Acute Graft-Versus-Host Disease
CP Wire
Wed, 12/19/18 - 10:36 am
Equillium
graft vs host disease
EQ001
Equillium's EQ001 Granted FDA Fast Track Designation for Acute Graft-Versus-Host Disease
Wed, 12/19/18 - 10:15 am
Equillium
graft vs host disease
FDA Grants Priority Review for Ruxolitinib (Jakafi) for Acute Graft-Versus-Host Disease
CP Wire
Thu, 10/25/18 - 09:52 am
FDA
Incyte
Novartis
Jakavi
Jakafi
graft vs host disease
FDA Grants Priority Review for Ruxolitinib (Jakafi) for Acute Graft-Versus-Host Disease
Thu, 10/25/18 - 09:35 am
Incyte
graft vs host disease
Novartis
Jakafi
Pages
« first
‹ previous
1
2
3
next ›
last »